Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-coupled neutral amino acid transporter 4 (SLC38A4) is a membrane transporter protein that mediates electrogenic symport of neutral amino acids and sodium ions across the cell membrane, primarily in the liver, placenta, and other tissues including kidney, muscle, and pancreas[1][3][5][7][10]. SLC38A4 has broad substrate specificity, favoring small neutral amino acids such as alanine, glycine, serine, asparagine, threonine, and glutamine, and also can transport cationic amino acids (e.g., arginine, lysine) by a Na(+)-independent mechanism[1][3][7][10]. It belongs to the solute carrier family (SLC), specifically family 38, and functions as both a system A and system N amino acid transporter, essential for maintaining amino acid homeostasis during cell growth, development, and metabolism[1][3][10]. SLC38A4 mutations have been linked to Mahvash Disease and abnormal fetal circulation; research suggests its key role in placental amino acid supply and metabolic adaptation during pregnancy[3][7].
Not applicable; no approved drugs or investigational agents specifically targeting SLC38A4 are documented in search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-coupled neutral amino acid transporter 4 (SLC38A4).